News, views and contacts from the global Pharmaceutical industry
 

News Archive

Archive of industry news from the global pharmaceutical industry

News By Date

September 2014

Top

Novo Nordisk introduces Ryzodeg in Mexico for type 2 diabetes
02 September 2014 Denmark-based Novo Nordisk has introduced Ryzodeg (insulin degludec/insulin aspart) in Mexico, which will be used to treat adult patients suffering from type 2 diabetes....

FDA clears sNDA for UCB’s Vimpat anti-epileptic drug as monotherapy
02 September 2014 The US Food and Drug Administration (FDA) has cleared a supplemental new drug application (sNDA) for UCB’s Vimpat (lacosamide) C-V as montherapy to treat partial-onset seizures in patients...

Pfizer and Protalix’s Elelyso receives FDA approval to treat type 1 Gaucher disease
01 September 2014 Pfizer and Protalix BioTherapeutics have secured approval from the US Food and Drug Administration (FDA) for Elelyso (taliglucerase alfa) to treat paediatric patients with type 1 Gaucher disease....

NIAID grants additional funding for BioCryst’s BCX4430 study to treat Ebola
01 September 2014 US-based BioCryst Pharmaceuticals has received an additional $2.4m funding from the National Institute of Allergy and Infectious Diseases (NIAID) to carry dose ranging efficacy study of...

August 2014

Top

UK Government to provide additional £160m to Cancer Drugs Fund
29 August 2014 The UK Government is set to add an additional £160m to the Cancer Drugs Fund, in order to improve treatment for patients....

Vifor Pharma’s Velphoro gets EU marketing authorisation to treat hyperphosphatemia
29 August 2014 Vifor Pharma has received EU marketing authorisation from the European Commission for its Velphoro (sucroferric oxyhydroxide) to treat hyperphosphatemia in adult CKD patients on dialysis....

DARPA’s ElectRx programme seeks to develop new customised therapies
28 August 2014 The US Defense Advanced Research Projects Agency (DARPA) has designed new electrical prescriptions (ElectRx) programme, to develop new high-precision and minimally invasive technologies to...

FDA clears GSK’s Promacta sNDA to treat SAA patients
28 August 2014 The US Food and Drug Administration (FDA) has given its clearance to supplemental new drug application (sNDA) for GlaxoSmithKline's (GSK) Promacta (eltrombopag) to treat patients with...

Venus signs agreement with Teva Canada to develop anti-cancer drug
27 August 2014 India-based Venus Remedies has signed a collaborative agreement with Teva Canada for an anti-cancer drug, which is under patent protection until 2016....

FDA grants orphan drug designation to Insys’ cannabidiol to treat GBM
27 August 2014 Insys Therapeutics has obtained orphan drug designation (ODD) from the US Food and Drug Administration (FDA) for its pharmaceutical cannabidiol (CBD) to treat glioblastoma multiforme (GBM),...

Roche to acquire InterMune for $8.3bn
26 August 2014 Swiss drugmaker Roche has signed a definitive merger agreement to acquire InterMune for around...

Alkermes submits new drug application for aripiprazole to treat Schizophreni
26 August 2014 The US Food and Drug Administration (FDA) has received a new drug application (NDA) from Ireland-based Alkermes for its aripiprazole lauroxil to treat...

CMDh recommends restricted use of bromocriptine to suppress lactation
22 August 2014 The Coordination Group for Mutual Recognition and Decentralised Procedures – Human (CMDh) has recommended the restricted use of bromocriptine to prevent or suppress breast milk...

Sunovion introduces new oral treatment Latuda for schizophrenia in UK
22 August 2014 Sunovion Pharmaceuticals Europe has revealed that Latuda (lurasidone), a new once-daily oral treatment, is available in the UK to treat schizophrenia in...

UK launches new Ebola research initiative
21 August 2014 The Wellcome Trust and the Department for International Development (DFID) have launched a new research initiative to restrict the spread of Ebola, which has claimed the lives of...

NICE recommends Celgene’s Revlimid to treat myelodysplastic syndromes
21 August 2014 The UK National Institute for Health and Care Excellence (NICE) has issued final draft guidance recommending Celgene's Revlimid (lenalidomide) to treat myelodysplastic syndromes...

Garvan and Roche to develop new technologies for targeted epigenomic analysis
21 August 2014 The Garvan Institute of Medical Research has collaborated with Roche Sequencing to develop new technologies for targeted epigenomic analysis using DNA...

Pfizer submits new drug application to FDA for breast cancer palbociclib drug
20 August 2014 US-based pharmaceutical company Pfizer has submitted a new drug application (NDA) for palbociclib to the US Food and Drug Administration...

Novartis signs exclusive worldwide licensing agreement with TB Alliance
20 August 2014 Swiss pharmaceutical firm Novartis has entered into an exclusive worldwide licensing agreement with the Global Alliance for TB Drug Development (TB Alliance), to provide drug candidate compounds...

AWMSG recommends Bayer’s Sativex to treat multiple sclerosis
19 August 2014 The All Wales Medicines Strategy Group (AWMSG) has recommended Bayer Healthcare’s Sativex Oromucosal Spray for symptom improvement in adult patients with moderate to severe spasticity due...

Roche’s Avastin plus chemotherapy receives FDA approval to treat cervical cancer
18 August 2014 Switzerland-based Roche has received approval from the US Food and Drug Administration (FDA) for its Avastin (bevacizumab), in combination with paclitaxel and cisplatin or paclitaxel and...